Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Gaynon

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|February 26, 1999
Distinct in vivo engraftment and growth patterns of t(1;19)+/E2A-PBX1+ and t(9;22)+/BCR-ABL+ human leukemia cells in SCID miceB J Waurzyniak, N Heerema, M G Sensel, et al.
The New England Journal of Medicine|June 6, 1998
Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapyJ B Nachman, H N Sather, M G Sensel, et al.
Cancer Treatment Reports|November 1, 1987
Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapyG H Reaman, P G Steinherz, P S Gaynon, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1988
Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Report of Children's Cancer Study Group Study CCG-193PP S Gaynon, W A Bleyer, P G Steinherz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group studyF M Uckun, P S Gaynon, M G Sensel, et al.
Leukemia|September 27, 2008
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group studyK Nguyen, M Devidas, S-C Cheng, et al.
Leukemia|March 5, 2004
Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children's Cancer GroupN A Heerema, J B Nachman, H N Sather, et al.
Journal of Pediatric Hematology/Oncology|March 1, 2000
Early testicular biopsy in males with acute lymphoblastic leukemia: lack of impact on subsequent event-free survivalM E Trigg, P G Steinherz, R Chappell, et al.
Leukemia|March 25, 2005
High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiativeM J Sutcliffe, J J Shuster, H N Sather, et al.
Leukemia & Lymphoma|June 1, 1997
Expression of BCR-ABL, E2A-PBX1, and MLL-AF4 fusion transcripts in newly diagnosed children with acute lymphoblastic leukemia: a Children's Cancer Group initiativeP S Gaynon, M L Crotty, H N Sather, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|February 26, 1999
Distinct in vivo engraftment and growth patterns of t(1;19)+/E2A-PBX1+ and t(9;22)+/BCR-ABL+ human leukemia cells in SCID miceB J Waurzyniak, N Heerema, M G Sensel, et al.
The New England Journal of Medicine|June 6, 1998
Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapyJ B Nachman, H N Sather, M G Sensel, et al.
Cancer Treatment Reports|November 1, 1987
Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapyG H Reaman, P G Steinherz, P S Gaynon, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1988
Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Report of Children's Cancer Study Group Study CCG-193PP S Gaynon, W A Bleyer, P G Steinherz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group studyF M Uckun, P S Gaynon, M G Sensel, et al.
Leukemia|September 27, 2008
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group studyK Nguyen, M Devidas, S-C Cheng, et al.
Leukemia|March 5, 2004
Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children's Cancer GroupN A Heerema, J B Nachman, H N Sather, et al.
Journal of Pediatric Hematology/Oncology|March 1, 2000
Early testicular biopsy in males with acute lymphoblastic leukemia: lack of impact on subsequent event-free survivalM E Trigg, P G Steinherz, R Chappell, et al.
Leukemia|March 25, 2005
High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiativeM J Sutcliffe, J J Shuster, H N Sather, et al.
Leukemia & Lymphoma|June 1, 1997
Expression of BCR-ABL, E2A-PBX1, and MLL-AF4 fusion transcripts in newly diagnosed children with acute lymphoblastic leukemia: a Children's Cancer Group initiativeP S Gaynon, M L Crotty, H N Sather, et al.
Pageof 7